(ĐTĐ) – The US Food and Drug Administration (FDA) has approved pregabalin (Lyrica, Pfizer Inc.) for the management of neuropathic pain associated with spinal cord injury, the company announced today. The drug was given priority review by the FDA for this indication, a statement from Pfizer notes, and brings to 5 the number of […]
